Thursday, May 6, 2021
ADVT 
Health

FDA OKs first new ADHD drug in over a decade for children

Darpan News Desk The Canadian Press, 06 Apr, 2021
  • FDA OKs first new ADHD drug in over a decade for children

U.S. regulators have approved the first new drug in over a decade for children with ADHD, which causes inattention, hyperactivity and impulsivity.

The Food and Drug Administration late Friday OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily.

Unlike nearly all other ADHD medicines, Qelbree is not a stimulant or a controlled substance, making it harder to abuse than older drugs. That’s been a problem with earlier ADHD treatments like Ritalin, nearly all of which contain the stimulants amphetamine or methylphenidate.

Qelbree, developed by Supernus Pharmaceuticals of Rockville, Maryland, carries a warning of potential for suicidal thoughts and behaviour, which occurred in fewer than 1% of volunteers in studies of the drug.

Supernus wouldn’t disclose the drug’s list price, but it’s sure to be higher than the many cheap generic ADHD pills.

ADHD affects about 6 million American children and adolescents. For many, problems include trouble paying attention and completing tasks, fidgeting and impulsiveness.

Experts say the drug may appeal to parents who don’t want to give their child stimulants.

It also could be an option for kids who have substance abuse problems, dislike the side effects of stimulants or need additional therapy, said Dr. David W. Goodman, director of Suburban Psychiatric Associates near Baltimore and an assistant professor of psychiatry at Johns Hopkins School of Medicine.

Goodman said most ADHD patients taking medication currently are prescribed long-acting stimulants, which are harder to to abuse to get a high than the original, fast-acting versions.

In a key late-stage study funded by Supernus, 477 children ages 6 to 11 took the drug for six weeks. Inattention and hyperactivity symptoms were reduced by about 50% compared to the placebo group. Qelbree, also known as viloxazine, helped reduce symptoms in some study volunteers within a week. Common side effects include sleepiness, lethargy, decreased appetite and headache.

Supernus is in late-stage testing for adults with ADHD. That’s a much smaller group than children, but that market is growing because few adults currently take ADHD medicines.

Viloxazine was sold as an antidepressant in Europe for several decades, but was never approved by the FDA. The maker ended sales for business reasons nearly two decades ago, as popular pills like Zoloft and Prozac came to dominate the market.

MORE Health ARTICLES

Swelling after COVID-19 shots may cause cancer false alarms

Swelling after COVID-19 shots may cause cancer false alarms

The main message: “This should not prevent patients from getting the vaccine,” stressed Chen, one of the coauthors.

Swelling after COVID-19 shots may cause cancer false alarms

PepsiCo goes Beyond Meat in new partnership

PepsiCo goes Beyond Meat in new partnership

The join venture gives Pepsi access to one of the leading plant-based meat companies at a time when consumers are increasingly cutting back on meat consumption and looking for healthier, more sustainable foods.

PepsiCo goes Beyond Meat in new partnership

A new COVID-19 challenge: Mutations rise along with cases

A new COVID-19 challenge: Mutations rise along with cases

Each new infection gives the virus a chance to mutate as it makes copies of itself, threatening to undo the progress made so far to control the pandemic.

A new COVID-19 challenge: Mutations rise along with cases

Docs urge pregnant women to get vaccinated

Docs urge pregnant women to get vaccinated

Dr. Samantha Hill, a cardiac surgeon in Toronto, says because pregnant and breastfeeding women haven't been included in clinical trials yet she is worried the message many pregnant women are getting is to not get vaccinated.

Docs urge pregnant women to get vaccinated

First blood test to help diagnose Alzheimer's goes on sale

First blood test to help diagnose Alzheimer's goes on sale

More than 5 million people in the United States and millions more around the world have Alzheimer’s, the most common form of dementia.

First blood test to help diagnose Alzheimer's goes on sale

What does emergency use of a COVID-19 vaccine mean?

What does emergency use of a COVID-19 vaccine mean?

Before any vaccine is permitted in the U.S., it must be reviewed by the Food and Drug Administration, which requires study in thousands of people.

What does emergency use of a COVID-19 vaccine mean?

PrevNext